Filing Flows › OptimizeRx (OPRX) › Q1 2026
OptimizeRx (OPRX) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 13, 2026
OptimizeRx (OPRX) reported revenue of $19.8M for the first quarter 2026 (Q1 2026), -10% from a year earlier and -38% from the quarter before. Operating margin was 2.0%, net loss $495K (2.5% of revenue).
OptimizeRx, Q1 2026: revenue $19.8M (-10% year over year), operating margin 2.0%, net loss $495K, operating cash flow −$467K. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $19.8M | -38% | -10% |
| Operating profit | $396K | -95% | — |
| Net earnings | −$495K | -110% | — |
| Operating cash flow | −$467K | -107% | -112% |
What changed
Revenue was $19.8M in Q1 2026, down 10% year over year and down 38% from the previous quarter.
Operating profit was $396K, a 2.0% margin (up 11.6 points year over year). The quarter ended with a net loss of $495K, after a profit of $5.0M the previous quarter. Net interest and other expense of $1.0M was the main reason.
Operating cash flow was −$467K. Non-cash charges added back $1.1M of depreciation and amortization and $1.8M of share-based compensation. Working capital and other items used $2.9M. Capital expenditures of $21K exceeded it, leaving free cash flow of −$488K.
Questions
What was OptimizeRx's revenue in the first quarter 2026?
OptimizeRx (OPRX) reported revenue of $19.8M for the first quarter 2026 (Q1 2026), -10% from a year earlier and -38% from the quarter before.
Was OptimizeRx profitable in the first quarter 2026?
Operating profit was $396K (2.0% of revenue) and net loss $495K.
Source: OptimizeRx 10-Q on SEC EDGAR.